ONWARD Medical Expands Board of Directors with New Leaders
In an exciting development for ONWARD Medical N.V. (NASDAQ: ONWD), the company is pleased to announce the appointment of Rob ten Hoedt to its Board of Directors. An esteemed figure in the medtech industry, Ten Hoedt has a distinguished history, including his roles as former President and Executive Vice-President at Medtronic, and as Chairman of MedTech Europe. His extensive expertise is expected to significantly enhance the strategic direction of the company as it continues its mission of creating innovative spinal cord stimulation therapies.
Leadership Transition and Strategic Goals
At the end of the year, Ten Hoedt will take over as Chairman from Jan Ohrstrom, who is stepping down after eight years of dedicated service. Ohrstrom's leadership has been pivotal in shaping ONWARD's vision and growth.
Focus on Innovation and Commercialization
Together with the addition of Rahma Samow, a seasoned leader in digital health and direct-to-consumer business, ONWARD Medical is poised to strengthen its market presence. Samow, who has held prominent positions at ClearChoice Dental Implant Centers and Siemens Healthineers, will contribute her valuable insights into commercial strategy and customer engagement.
A Vision for Future Growth
Ten Hoedt expressed his enthusiasm for joining the ONWARD team, stating, "I am honored and excited to join the Board of this exceptional Company. I have always been drawn to opportunities to make a difference, address unmet needs, and confront unsolved challenges." His commitment to innovation aligns with ONWARD's goals as it prepares for the anticipated launch of its ARC-EX System in the US, currently under FDA review.
Strengthening Relationships in the Medical Community
Dave Marver, CEO of ONWARD Medical, is optimistic about the impact Ten Hoedt and Samow will have on the company's future. He highlighted their rich backgrounds and established networks within the medtech community, which are critical as ONWARD seeks to develop and commercialize its groundbreaking therapies.
Shifting Market Dynamics and New Directions
As ONWARD transitions into a fully commercial entity, the leadership changes herald a new era of growth and innovation. The focus on digital health is particularly timely, as the healthcare landscape increasingly evolves toward patient-centric solutions. With Samow on board, ONWARD aims to enhance its outreach efforts and build stronger connections with patients and their families.
Recognition of Past Contributions
During this transition, Marver has been vocal in expressing gratitude for the contributions of Ohrstrom and Fred Colen. Both have played influential roles in sculpting the company's journey and have left an indelible mark on its culture and direction. Colen's experience in R&D has been invaluable, and his insights have helped guide ONWARD through its growth phases.
Commitment to Innovative Therapy Development
ONWARD Medical continues to push boundaries in spinal cord injury therapies, bolstered by its scientific research and technological advancements. The company has developed its flagship ARC Therapy™, which has gained multiple Breakthrough Device Designations from the FDA due to its potential to restore movement and improve quality of life for individuals with spinal cord injuries. These innovations reflect ONWARD's dedication to advancing medical technology and improving patient care.
Insights on Future Directions
The recent appointments mark a strong commitment to ONWARD's goals of expanding its operations and enhancing its product offerings. Both Ten Hoedt and Samow are expected to bring fresh perspectives that align with the company’s mission of establishing effective care solutions for those affected by spinal injuries.
Frequently Asked Questions
Who has joined ONWARD Medical's Board of Directors?
Rob ten Hoedt and Rahma Samow have been appointed to ONWARD Medical's Board of Directors.
What roles did Ten Hoedt hold before joining ONWARD?
Ten Hoedt served as President and Executive Vice-President at Medtronic and was the Chairman of MedTech Europe.
What is the main focus of ONWARD Medical?
ONWARD Medical focuses on restoring movement, function, and independence for individuals with spinal cord injuries through innovative therapies.
When is the ARC-EX System expected to launch in the US?
The ARC-EX System’s launch date is anticipated soon, with ongoing FDA reviews taking place.
What has been the impact of Jan Ohrstrom's leadership?
Jan Ohrstrom's leadership has significantly shaped ONWARD’s vision and laid the groundwork for its growth as a public company.
